Skip to main content
. 2020 Nov 3;10:526514. doi: 10.3389/fonc.2020.526514

Table 1.

Patient demographics and surgical factors by PBD.

PBD
N No (n=73) Yes (n=84) p-Value
Patient Demographics
Age at MDT Assessment (Years) 157 66.2 ± 8.7 68.9 ± 9.7 0.075
Gender (% Male) 157 36 (49%) 47 (56%) 0.427
BMI 152 26.7 ± 4.9 27.4 ± 5.5 0.152
CCI 157 0.199*
2-3 14 (19%) 15 (18%)
4-5 41 (56%) 38 (45%)
6+ 18 (25%) 31 (37%)
Smoking Status 157 0.286
No 60 (82%) 71 (85%)
Current 10 (14%) 6 (7%)
Ex 3 (4%) 7 (8%)
CA19-9 (U/ml) 135 307 (116–959) 318 (92–1718) 0.643
Surgery 157 73 (100%) 61 (73%) <0.001
Surgical Factors
Days from Diagnosis to Surgery** 134 14 (10–21) 59 (45–77) <0.001
Bilirubin (at Surgery, µmol/L)** 133 307 (222–411) 15 (8–61) <0.001
Type of Surgery** 134 <0.001
Resection 71 (97%) 45 (74%)
Bypass 2 (3%) 16 (26%)
Vein Reconstruction*** 116 20 (28%) 8 (18%) 0.292
T-Stage*** 116 0.496*
T1 13 (18%) 9 (20%)
T2 55 (77%) 30 (67%)
T3 3 (4%) 6 (13%)
N-Stage*** 116 0.547*
N0 9 (13%) 4 (9%)
N1 32 (45%) 20 (44%)
N2 30 (42%) 21 (47%)
Overall Stage*** 116 0.468*
1 8 (11%) 3 (7%)
2 32 (45%) 20 (44%)
3 31 (44%) 22 (49%)
R-Status (% R1)*** 116 29 (41%) 17 (38%) 0.846
LN ratio*** 116 0.19 (0.07–0.36) 0.21 (0.06–0.33) 0.966

Patient demographics are reported for the cohort as a whole, while surgical factors are reported only for the subgroup who underwent surgery (N=73/61 for PBD No/Yes), and tumor staging and resection-related factors for the subgroup that underwent resection (N=71/45). Continuous data are reported as mean ± SD, or as median (interquartile range), with p-values from Mann-Whitney U tests. Categorical data are reported as N (%), with p-values from Fisher’s exact tests or Chi-square. Bold p-values are significant at p<0.05. *p-Value from a Mann-Whitney U test, as the factor is ordinal. **In patients undergoing surgery; time is from initial CT scan. ***In patients undergoing resection.

MDT, multidisciplinary team; BMI, body mass index; CCI, Charlson Comorbidity Index; LN ratio, lymph node ratio.